BDBM713311 (Method 8):(E)-1-((R)-3-((7-(8-chloro-7-fluoronaphthalen-1-yl)-8-fluoro-2-(((2R,7aS)-2-fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl)methoxy)pyrido[4,3-d]pyrimidin-4-yl)(methyl)amino)pyrrolidin-1-yl)-3-((R)-1-(2-hydroxyethyl)azetidin-2-yl)prop-2-en-1-one::US20250019387, Example 222
SMILES CN(c1nc(OC[C@@]23CCCN2C[C@H](F)C3)nc2c(F)c(-c3cccc4ccc(F)c(Cl)c34)ncc12)[C@@H]1CCN(C(=O)/C=C/[C@H]2CCN2CCO)C1
InChI Key InChIKey=RBDJWDBGOVLGKQ-UHFFFAOYSA-N
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 713311
TargetGTPase KRas [G12C,C51S,C80L,C118S]/RAF proto-oncogene serine/threonine-protein kinase(Human)
Frontier Medicines
US Patent
Frontier Medicines
US Patent
Affinity DataIC50: 10nMAssay Description:The AlphaScreen technology was used to determine IC50s for compound inhibition of KRAS G12C (present as the Cys-light (C51S, C80L and C118S), truncat...More data for this Ligand-Target Pair
